Tempus AI has agreed to acquire the cancer genomics company Personalis in a deal valued at about $1.5 billion, the companies announced July 20. The acquisition builds on a partnership the two companies formed in November 2023, when Tempus invested…
Artificial Intelligence
Somerville, Mass.-based Mass General Brigham and Boston-based Dana-Farber Cancer Institute have developed an AI tool to predict cancer spread in patients with oropharyngeal carcinoma. The noninvasive tool uses CT imaging data to estimate the number of lymph nodes with pathologic…
Providence, based in Renton, Wash., Microsoft Research and the University of Washington have developed an AI pathology model that researchers say can map how immune cells interact with tumors on a scale not previously possible. The model, called GigaTIME, was…